Abstract

The process of ageing denotes a postmaturational deterioration of cells and organisms with the passage of time, an increased vulnerability to challenges and a decreased ability to survive. Causes may be found in oxidative damage and incomplete cell maintenance, and both of these factors may be considered the primary targets of any antiageing therapy. Levels of lipophylic anti-oxidant defences may be the limiting factor of longevity in ad-libitum fed animals. An appropriate administration of lipophylic antioxidants (e.g., polyunsaturated fatty acids, vitamin E) and the stimulation of cytomembrane and organelle renewal, by calorie restriction and pharmacological intensification of autophagy, are currently available interventions that may extend longevity and retard the onset, as well as aid the treatment, of most age-associated diseases.

Keywords

LongevityAutophagyCalorie restrictionBiologyVitamin ELimitingAgeingPolyunsaturated fatty acidCell biologyPharmacologyEndocrinologyBiochemistryGeneticsAntioxidant

MeSH Terms

AgingAnimalsAntioxidantsDrug Delivery SystemsHumansOxidative Stress

Affiliated Institutions

Related Publications

Publication Info

Year
2005
Type
review
Volume
9
Issue
1
Pages
77-82
Citations
11
Access
Closed

Social Impact

Altmetric

Social media, news, blog, policy document mentions

Citation Metrics

11
OpenAlex
0
Influential
8
CrossRef

Cite This

Ettore Bergamini (2005). Targets for antiageing drugs. Expert Opinion on Therapeutic Targets , 9 (1) , 77-82. https://doi.org/10.1517/14728222.9.1.77

Identifiers

DOI
10.1517/14728222.9.1.77
PMID
15757483

Data Quality

Data completeness: 81%